白蛋白生物分子图谱可识别急性肝衰竭的严重程度特征与早期死亡信号
研究对225名参与者(200例急性肝衰竭患者和25名健康对照)的白蛋白进行纯化,分析其修饰、功能及结合的多组学特征,并在测试队列中验证。结果显示急性肝衰竭患者白蛋白过度氧化且功能显著失调,基于多组学特征预测死亡的准确率超过90%,代谢物组合诊断准确率达98%(AUC 0.98,95%CI 0.95-1.0),可区分易发生早期死亡的患者。
要点
- 急性肝衰竭患者白蛋白较健康对照更氧化、糖基化,非存活者更明显(p<0.05)。
- 基于前五种代谢物的组合诊断准确率98%(AUC 0.98,95%CI 0.95-1.0),可区分易早期死亡患者。
- 多组学特征预测非存活概率>90%,与白蛋白功能及临床参数直接相关(r2>0.85)。
核心结论
- 急性肝衰竭中白蛋白过度氧化且功能显著失调。
- 研究勾勒出可区分易发生早期死亡或需紧急肝移植的急性肝衰竭患者的白蛋白组学特征。
研究设计与样本
- 共纳入225名参与者(200例急性肝衰竭患者和25名健康对照)。
- 训练队列:急性肝衰竭40例(存活8例,非存活32例),健康对照5例。
- 测试队列:急性肝衰竭160例(存活53例,非存活107例),健康对照20例。
主要发现
- 急性肝衰竭患者白蛋白较健康对照更氧化和糖基化,多组学特征不同,非存活者更明显(p<0.05)。
- 非存活者白蛋白更常与炎症相关蛋白、晚期糖基化终产物、精氨酸和脯氨酸代谢相关代谢物、胆汁酸及线粒体分解产物结合(p<0.05,错误发现率<0.01)。
- 非存活者中增加的细菌分类群(李斯特菌、梭菌等)与脂质(甘油三酯[4:0/12:0/12:0]和磷脂酰丝氨酸[39:0])及代谢物(卟胆原和烟酸)相关(r2>0.7)。
- 基于前五种代谢物(烟酸、L-乙酰肉碱、L-肉碱、孕烯醇酮硫酸盐和N-(3-羟基丁酰基)-L-高丝氨酸内酯)的概率检测代谢物诊断准确率98%(AUC 0.98,95%CI 0.95-1.0),可区分易早期死亡患者(log-rank<0.05)。
关键数值与推荐
- 多组学特征检测非存活的概率>90%,与白蛋白功能及临床参数直接相关(r2>0.85)。
- 在测试队列1(血浆和配对一滴血)中使用高分辨率质谱和五种机器学习算法验证,代谢组面板预测死亡的准确率/灵敏度及特异度>92%。
临床怎么用
- 本临床前研究验证了白蛋白组学分析用于理解急性肝衰竭病理生理和开发不良结局指标的实用性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute liver failure (ALF) is associated with high mortality. Alterations in albumin structure and function have been shown to correlate with outcomes in cirrhosis. We undertook a biomolecular analysis of albumin to determine its correlation with hepatocellular injury and early mortality in ALF. METHODS: Altogether, 225 participants (200 patients with ALF and 25 healthy controls [HC]) were enrolled. Albumin was purified from the baseline plasma of the training cohort (ALF, n = 40; survivors, n = 8; non-survivors, n = 32; and HC, n = 5); analysed for modifications, functionality, and bound multi-omics signatures; and validated in a test cohort (ALF, n = 160; survivors, n = 53; non-survivors, n = 107; and HC, n = 20). RESULTS: In patients with ALF, albumin is more oxidised and glycosylated with a distinct multi-omics profile than that in HC, more so in non-survivors (p <0.05). In non-survivors, albumin was more often bound (p <0.05, false discovery rate <0.01) to proteins associated with inflammation, advanced glycation end product, metabolites linked to arginine, proline metabolism, bile acid, and mitochondrial breakdown products. Increased bacterial taxa (Listeria, Clostridium, etc.) correlated with lipids (triglycerides [4:0/12:0/12:0] and phosphatidylserine [39:0]) and metabolites (porphobilinogen and nicotinic acid) in non-survivors (r2 >0.7). Multi-omics signature-based probability of detection for non-survival was >90% and showed direct correlation with albumin functionality and clinical parameters (r2 >0.85). Probability-of-detection metabolites built on the top five metabolites, namely, nicotinic acid, l-acetyl carnitine, l-carnitine, pregnenolone sulfate, and N-(3-hydroxybutanoyl)-l-homoserine lactone, showed diagnostic accuracy of 98% (AUC 0.98, 95% CI 0.95-1.0) and distinguish patients with ALF predisposed to early mortality (log-rank <0.05). On validation using high-resolution mass spectrometry and five machine learning algorithms in test cohort 1 (plasma and paired one-drop blood), the metabolome panel showed >92% accuracy/sensitivity and specificity for prediction of mortality. CONCLUSIONS: In ALF, albumin is hyperoxidised and substantially dysfunctional. Our study outlines distinct 'albuminome' signatures capable of distinguishing patients with ALF predisposed to early mortality or requiring emergency liver transplantation. IMPACTS AND IMPLICATIONS: Here, we report that the biomolecular map of albumin is distinct and linked to severity and outcome in patients with acute liver failure (ALF). Detailed structural, functional, and albumin-omics analysis in patients with ALF led to the identification and classification of albumin-bound biomolecules, which could segregate patients with ALF predisposed to early mortality. More importantly, we found albumin-bound metabolites indicative of mitochondrial damage and hyperinflammation as a putative indicator of <30-day mortality in patients with ALF. This preclinical study validates the utility of albuminome analysis for understanding the pathophysiology and development of poor outcome indicators in patients with ALF.
引用
- Sharma N, Pandey S, Yadav M, et al. Biomolecular map of albumin identifies signatures of severity and early mortality in acute liver failure. J Hepatol. 2023. PMID: 37116716. doi:10.1016/j.jhep.2023.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。